Duan Hong-Bing, Cao Jun-Tao, Yang Jiu-Jun, Wang Hui, Liu Yan-Ming
College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang 464000, China.
College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang 464000, China.
Talanta. 2016 Jul 1;154:341-5. doi: 10.1016/j.talanta.2016.03.093. Epub 2016 Mar 29.
A new method of capillary electrophoresis (CE) coupled with tris(2, 2'-bipyridyl) ruthenium(II) electrochemiluminescence (ECL) detection has been developed to detect four local anesthetics procainamide (PAH), tetracaine (TCH), proparacaine (PCH) and cinchocaine (CIN) simultaneously. An europium (III)-doped prussian blue analogue film (Eu-PB) modified platinum electrode was prepared and applied to improve the detection sensitivity. The parameters including additives, concentration and pH of the running buffer, separation voltage and detection potential that affect CE separation and ECL detection were optimized in detail. The four local anesthetics were baseline separated and detected within 10min under the optimized conditions. The detection limits (LOD) of PAH, TCH, PCH and CIN are 5.5×10(-8), 9.6×10(-8), 2.5×10(-8) and 3.5×10(-8)molL(-1) (S/N=3), respectively. RSDs of the migration time for four analytes range from 1.2% to 2.5% within intraday and from 2.4% to 4.9% in interday, RSDs of the peak area for four analytes are from 1.7% to 3.3% within intraday and from 2.2% to 5.6% in interday, respectively. The limits of quantitation (LOQ) (S/N=10) for PAH, TCH, PCH and CIN in human urine sample are 5.9×10(-7), 9.2×10(-7), 8.3×10(-7) and 5.0×10(-7)molL(-1), separately. The recoveries (n=3) of four analytes in human urine are from 87.6% to 107.7% with less than 5.9% in RSDs. The developed method was used to determine four local anesthetics in human urine samples and investigate the interaction between PAH and human serum albumin (HSA). The number of binding sites and the binding constant of PAH with HSA were calculated to be 1.03 and 2.4×10(4)Lmol(-1), respectively.
已开发出一种毛细管电泳(CE)与三(2,2'-联吡啶)钌(II)电化学发光(ECL)检测联用的新方法,用于同时检测四种局部麻醉剂:普鲁卡因酰胺(PAH)、丁卡因(TCH)、丙美卡因(PCH)和辛可卡因(CIN)。制备了一种铕(III)掺杂普鲁士蓝类似物薄膜(Eu-PB)修饰的铂电极,并用于提高检测灵敏度。详细优化了影响CE分离和ECL检测的参数,包括运行缓冲液的添加剂、浓度和pH值、分离电压和检测电位。在优化条件下,四种局部麻醉剂在10分钟内实现基线分离并检测。PAH、TCH、PCH和CIN的检测限(LOD)分别为5.5×10(-8)、9.6×10(-8)、2.5×10(-8)和3.5×10(-8)molL(-1)(S/N=3)。四种分析物迁移时间的日内相对标准偏差(RSD)范围为1.2%至2.5%,日间为2.4%至4.9%;四种分析物峰面积的日内RSD为1.7%至3.3%,日间为2.2%至5.6%。人尿样中PAH、TCH、PCH和CIN的定量限(LOQ)(S/N=10)分别为5.9×10(-7)、9.2×10(-7)、8.3×10(-7)和5.0×10(-7)molL(-1)。四种分析物在人尿中的回收率(n=3)为87.6%至107.7%,RSD小于5.9%。所开发的方法用于测定人尿样中的四种局部麻醉剂,并研究PAH与人血清白蛋白(HSA)之间的相互作用。计算得出PAH与HSA的结合位点数和结合常数分别为1.03和2.4×10(4)Lmol(-1)。